Arcus Biosciences (NYSE:RCUS) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsBob Goeltz - CFODaniel Bronder - Equity Research AssociateHolli Kolkey - VP of Corporate AffairsJen Jarret - COOJonathan Miller - Managing DirectorJuan Jaen - President and Co-FounderRichard Marcus - CMOSalim Syed - Managing DirectorTerry Rosen - CEOYigal Nochomovitz - Director, Biotech Equity ResearchConference Call ParticipantsEmily Bodnar - Biotech Equity Research AnalystNone - AnalystNone - AnalystNone ...

Arcus Biosciences J.P. Morgan Healthcare Conference 2026 Oncology and Immunology Portfolio January 14, 2026 Forward-looking Statements/Safe Harbor Forward-Looking Statements Safe Harbor: This presentation contains forward-looking statements about Arcus Biosciences, Inc. ("we," "Arcus" or the "Company") made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements in this presentation that are not historical facts are forward-looking statements, including ...